Skip to main content
. 2023 Jul 2;62(7):2891–2904. doi: 10.1007/s00394-023-03201-0

Table 2.

Associations of pre-diagnostic energy-adjusted intake of total dairy, low-fat dairy, high-fat dairy, and dairy products with recurrence (n = 1315) and all-cause mortality (n = 1731) in sex-specific quartiles of people with stage I-III colorectal cancer

Dietary variable Recurrencea All-cause mortality
Median energy-adjusted intake [IQR]b n No. of recurrences/person-years Multivariable HR (95% CI)c Median energy-adjusted intake [IQR]b n No. of deaths/person-years Multivariable HR (95% CI)c
Total dairy
 Q1 109.8 [69.7, 142.4] 331 55/1033 1.00 114.3 [73.0, 147.3] 432 74/2534 1.00
 Q2 220.3 [184.3, 253.9] 330 46/1063 0.80 (0.54–1.19) 224.5 [190.0, 247.3] 432 78/2504 0.98 (0.71–1.35)
 Q3 323.2 [278.1, 351.3] 326 42/1049 0.72 (0.48–1.08) 322.5 [279.1, 348.9] 430 64/2485 0.77 (0.55–1.09)
 Q4 489.6 [426.1, 591.02] 328 30/1106 0.51 (0.33–0.80) 481.0 [423.7, 581.2] 437 66/2582 0.72 (0.52–1.01)
 Ptrend NA NA NA 0.003 NA NA NA 0.029
 Continuous (per 100 g/day) 267.9 [172.1, 385.4] 1315 173/4251 0.89 (0.81–0.99) 269.6 [177.6, 384.6] 1731 282/10105 0.96 (0.89–1.03)
Low-fat dairyd
 Q1 20.5 [− 4.8, 42.3] 333 56/1076 1.00 20.5 [− 3.5, 44.6] 434 87/2511 1.00
 Q2 120.1 [94.8, 142.0] 329 46/1034 0.83 (0.56–1.23) 119.7 [94.9, 143.7] 438 74/2503 0.84 (0.62–1.15)
 Q3 223.0 [184.0, 254.9] 325 47/1035 0.84 (0.57–1.24) 219.6 [185.9, 253.4] 425 63/2474 0.69 (0.50–0.96)
 Q4 374.3 [317.8, 465.4] 328 24/1108 0.42 (0.26–0.67) 371.9 [315.4, 452.4] 434 58/2618 0.58 (0.41–0.81)
 Ptrend NA NA NA  < .001 NA NA NA  < 0.001
 Continuous (per 100 g/day) 163.3 [68.2, 281.4] 1315 173/4251 0.86 (0.77–0.96) 164.8 [69.7, 281.2] 1731 282/10105 *
High-fat dairye
 Q1 25.4 [6.3, 36.9] 328 45/1044 1.00 24.5 [5.5, 36.9] 428 49/2553 1.00
 Q2 60.7 [50.9, 68.7] 329 38/1065 0.80 (0.51–1.24) 61.3 [51.5, 69.0] 430 67/2525 1.13 (0.78–1.66)
 Q3 96.7 [85.9, 109.2] 325 43/1068 0.93 (0.60–1.44) 96.8 [86.2, 109.2] 431 80/2483 1.33 (0.92–1.93)
 Q4 180.3 [149.6, 229.8] 333 47/1075 0.97 (0.64–1.47) 182.9 [149.8, 244.3] 442 86/2545 1.41 (0.98–2.01)
 Ptrend NA NA NA 0.83 NA NA NA 0.06
 Continuous (per 100 g/day) 76.0 [45.6, 128.5] 1315 173/4251 1.07 (0.91–1.26) 77.7 [46.5, 127.9] 1731 282/10105 1.15 (1.03–1.28)
Total milk
 Q1 − 4.2 [-19.1, 7.1] 331 43/1055 1.00 − 4.9 [-19.4, 6.7] 424 60/2508 1.00
 Q2 31.8 [21.2, 41.4] 328 51/984 1.06 (0.69–1.64) 30.9 [21.1, 40.5] 432 75/2399 1.07 (0.75–1.55)
 Q3 93.8 [69.6, 120.4] 330 40/1100 0.89 (0.57–1.40) 89.6 [67.4, 116.5] 439 74/2558 1.09 (0.76–1.55)
 Q4 231.5 [175.1, 304.3] 326 39/1112 0.81 (0.52–1.27) 227.0 [171.1, 297.5] 436 73/2641 0.91 (0.64–1.29)
 Ptrend NA NA NA 0.23 NA NA NA 0.39
 Continuous (per 100 g/day) 52.2 [15.3, 145.8] 1315 173/4251 0.90 (0.78–1.04) 51.2 [15.5, 142.5] 1731 282/10105 1.02 (0.92–1.12)
Total yoghurt
 Q1 2.4 [− 7.1, 9.9] 325 43/1088 1.00 2.4 [− 6.1, 11.3] 427 78/2531 1.00
 Q2 45.8 [22.2, 62.0] 328 48/1040 1.14 (0.75–1.72) 45.3 [22.5, 68.0] 429 80/2449 0.91 (0.66–1.25)
 Q3 102.3 [76.1, 122.0] 333 49/1074 1.09 (0.72–1.64) 102.3 [76.4, 124.7] 438 68/2588 0.74 (0.53–1.02)
 Q4 205.0 [147.1, 277.2] 329 33/1049 0.78 (0.50–1.24) 204.6 [147.5, 273.6] 437 56/2537 0.70 (0.50–0.99)
 Ptrend NA NA NA 0.21 NA NA NA 0.029
 Continuous (per 100 g/day) 70.8 [18.5, 138.4] 1315 173/4251 0.96 (0.83–1.13) 72.8 [19.9, 140.1] 1731 282/10105 0.86 (0.75–0.99)
Total cheese
 Q1 9.0 [2.5, 12.6] 329 47/1065 1.00 8.6 [2.4, 12.4] 429 63/2518 1.00
 Q2 21.6 [19.4, 25.1] 325 35/1048 0.76 (0.49–1.18) 21.5 [19.0, 24.8] 429 64/2523 0.92 (0.65–1.32)
 Q3 34.8 [31.1, 38.1] 331 47/1007 0.97 (0.64–1.46) 34.5 [31.1, 37.4] 436 78/2449 1.08 (0.77–1.51)
 Q4 57.2 [49.1, 73.3] 330 44/1131 0.91 (0.60–1.38) 57.6 [49.1, 74.0] 437 77/2615 1.04 (0.75–1.46)
 Ptrend NA NA NA 0.95 NA NA NA 0.61
 Continuous (per 30 g/day) 28.0 [16.1, 43.7] 1315 173/4251 1.03 (0.85–1.24) 27.8 [15.9, 43.2] 1731 282/10105 1.03 (0.89–1.19)

CI confidence interval, HR hazard ratio, IQR inter-quartile range. Cut-off points for female quartiles were as follows: 220.8, 308.1 and 441.3 g/day for total dairy; 101.4, 201.4 and 313.5 g/day for low-fat dairy; 58.0, 84.0 and 129.1 g/day for high-fat dairy; 23.6, 60.0 and 149.6 g/day for milk; 40.7, 104.6 and 164.6 g/day for yoghurt; 17.9, 29.8 and 44.8 g/day for cheese. Cut-off points for male quartiles were as follows: 152.1, 244.1 and 358.0 g/day for total dairy; 56.6, 145.7 and 264.0 g/day for low-fat dairy; 38.0, 72.5 and 123.1 g/day for high-fat dairy; 9.4, 46.0 and 137.2 g/day for milk; 9.7, 54.7 and 120.5 g/day for yoghurt; 14.3, 26.2 and 41.9 g/day for cheese

*This association was observed to be non-linear in restricted cubic splines. See Fig. 2 for the continuous analysis

aRecurrence is defined as a locoregional recurrence or distant metastasis. Participants were excluded from data analysis when they had missing data on recurrence status (n = 463) or when they had no surgery (n = 8) 

bDietary intake was adjusted for energy using the energy residual method. To improve interpretability, the predicted nutrient intake at the median total energy intake was added to individual residuals [15

cThe adjusted model was adjusted for age, sex, stage of disease and pre-diagnostic energy intake

dLow-fat dairy included buttermilk and low-fat, reduced-fat or skimmed versions of milk, yoghurt, custard, and soft curd cheese 

eHigh-fat dairy included whole and condensed milk, full-fat versions of yoghurt, custard and soft curd cheese, all other cheeses, ice cream, whipped cream, and butter